Anzeige
Mehr »
Login
Donnerstag, 23.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Amazon investiert Millionen in Kernenergie - so können Sie sich früh positionieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40E0P | ISIN: US3622AW3040 | Ticker-Symbol:
NASDAQ
22.01.25
21:57 Uhr
0,685 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GRI BIO INC Chart 1 Jahr
5-Tage-Chart
GRI BIO INC 5-Tage-Chart

Aktuelle News zur GRI BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.01.GRI Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
23.12.24GRI Bio, Inc.: GRI Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent Covering GRI-0803 and Its Library of 500+ Proprietary Compounds93- Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA, CA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ("GRI...
► Artikel lesen
20.12.24GRI Bio, Inc. - 8-K, Current Report-
06.12.24GRI Bio, Inc.: GRI Bio to Participate in the Virtual Investor Closing Bell Series3
21.11.24GRI Bio reports progress in IPF treatment with GRI-06211
21.11.24GRI Bio vermeldet Fortschritte bei IPF-Behandlung mit GRI-0621-
21.11.24GRI Bio, Inc.: GRI Bio Showcases GRI-0621's Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)108Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit Data demonstrate that NKT cells are activated in airways in IPF patients...
► Artikel lesen
GRI BIO Aktie jetzt für 0€ handeln
15.11.24GRI Bio reports 9M results1
14.11.24GRI Bio files to sell 1.58M shares of common stock for holders2
14.11.24GRI Bio, Inc.: GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis109$13.9 million in gross proceeds raised since the beginning of 2024 extending expected cash runway into mid Q1 2025 and through interim data readout from GRI-0621 Phase 2a biomarker study Topline...
► Artikel lesen
14.11.24GRI Bio, Inc. - 8-K, Current Report1
24.10.24GRI Bio sichert Finanzierung zur Weiterentwicklung der IPF-Behandlung bis 20252
24.10.24GRI Bio, Inc.: GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024148Proceeds from recent exercise of warrants estimated to extend cash runway into mid Q1 2025, including interim data readout from Phase 2a biomarker study of lead program, GRI-0621 for the treatment...
► Artikel lesen
22.10.24GRI BIO, Inc. - 8-K, Current Report3
21.10.24GRI Bio, Inc.: GRI Bio Announces Exercise of Warrants9
16.10.24GRI Bio reports progress in IPF treatment study3
16.10.24GRI Bio, Inc.: GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621's Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)3
08.10.24Ascendiant Capital sets 12-month target on GRI Bio with Buy rating2
08.10.24Ascendiant Capital setzt 12-Monats-Kursziel für GRI Bio mit Kaufempfehlung2
07.10.24GRI Bio, Inc.: GRI Bio to Present at the 22nd International Colloquium on Lung and Airway Fibrosis2
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1